IMTX

Immatics N.V.

Healthcare›Biotechnology|NASDAQ Capital Market|DE

Price

$10.35

Market Cap

$1.39B

Beta

1.35

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-69.06%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y-34.64%

P/E Ratio0.0

PEG Ratio—

FCF Yield-13.14%

Debt / Equity0.03

Interest Coverage-197.4x

No credit card required

Already have an account? Sign in to view the full analysis for IMTX.